☆ 4.7 Article

Leveraging Ligand Affinity and Properties: Discovery of Novel Benzamide-Type Cereblon Binders for the Design of PROTACs

JOURNAL OF MEDICINAL CHEMISTRY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Chemistry, Medicinal

Synthesis of novel glutarimide ligands for the E3 ligase substrate receptor Cereblon (CRBN): Investigation of their binding mode and antiproliferative effects against myeloma cell lines

Mikhail Krasavin et al.

Summary: In order to enhance the chemical toolkit for targeted protein degradation, the authors developed a new series of non-thalidomide Cereblon (CRBN) ligands. By using a thio-Michael addition reaction, readily available 2-methylidene glutarimide was converted to a series of 2-((hetero)aryl(methyl))thio glutarimides. These compounds were evaluated for their affinity to human CRBN and their binding modes were studied through X-ray crystallography. The newly identified Cereblon ligands show promising potential for the synthesis of novel PROTAC protein degraders.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2023)

添加到收藏夹

Article Chemistry, Medicinal

Phenyl Dihydrouracil: An Alternative Cereblon Binder for PROTAC Design

Jamie A. Jarusiewicz et al.

Summary: Phenyl dihydrouracil (PD)-based PROTACs have shown improved chemical stability and eliminated racemization-prone chiral center compared to IMiD and PG analogues. These PD-PROTACs exhibited enhanced physicochemical and pharmacological properties.

ACS MEDICINAL CHEMISTRY LETTERS (2023)

添加到收藏夹

Article Biochemical Research Methods

Tunable Heteroaromatic Nitriles for Selective Bioorthogonal Click Reaction with Cysteine

Matic Proj et al.

Summary: The binucleophilic properties of 1,2-aminothiol and its rare occurrence in nature make it a useful reporter for tracking molecules in living systems. In this study, we expand the chemical space of heteroaromatic nitriles for bioconjugation under physiologically relevant conditions. We provide highly selective and moderately reactive nitriles as well as highly reactive yet less selective analogs with a variety of enabling attachment chemistries to aid future applications in bioconjugation, chemical biology, and nanomaterial science.

BIOCONJUGATE CHEMISTRY (2023)

添加到收藏夹

Article Chemistry, Medicinal

Development of Substituted Phenyl Dihydrouracil as the Novel Achiral Cereblon Ligands for Targeted Protein Degradation

Haibo Xie et al.

Summary: Substituted achiral phenyl dihydrouracil (PDHU) was developed as a novel class of CRBN ligands for PROTACs. Some substituted PDHUs showed comparable binding affinity to lenalidomide. Structural modeling provided insights into the molecular interactions between PDHU ligands and CRBN. PDHUs also demonstrated greater stability than lenalidomide. Finally, potent BRD4 degraders were developed using trisubstituted PDHUs.

JOURNAL OF MEDICINAL CHEMISTRY (2023)

添加到收藏夹

Article Biochemistry & Molecular Biology

Cereblon neo-substrate binding mimics the recognition of the cyclic imide degron

Christopher Heim et al.

Summary: In targeted protein degradation, immunomodulatory drugs (IMiDs) or cereblon (CRBN) E3 ligase modulatory drugs (CELMoDs) recruit neo-substrate proteins to CRBN for degradation. The recognition mode of natural CRBN degron is described, and it is found that the binding of neo-substrates closely mimics the recognition of natural degrons. The structural basis for the rational design of CRBN effectors is completed.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2023)

添加到收藏夹

Article Chemistry, Medicinal

Development of PDE6D and CK1α Degraders through Chemical Derivatization of FPFT-2216

Mingxing Teng et al.

Summary: Immunomodulatory drugs approved for multiple myeloma treatment exert effects by inducing interactions between the CRL4(CRBN) E3 ubiquitin ligase and a zinc finger degron motif, degrading specific targets. FPFT-2216 compound was shown to degrade PDE6D, IKZF1, IKZF3, and CK1a, leading to the development of more selective degraders TMX-4100 and TMX-4116 targeting PDE6D and CK1a. PDE6D depletion by FPFT-2216 does not impede the growth of KRAS-dependent cells, illustrating challenges in drugging PDE6D-KRAS.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

添加到收藏夹

Article Biochemical Research Methods

High-resolution structures of the bound effectors avadomide (CC-122) and iberdomide (CC-220) highlight advantages and limitations of the MsCI4 soaking system

Christopher Heim et al.

Summary: This study investigated the binding modes of next-generation IMiDs drugs on Cereblon using a crystal-soaking system, providing important insights for the development of future cereblon effectors.

ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2022)

添加到收藏夹

Article Pharmacology & Pharmacy

Redox active or thiol reactive? Optimization of rapid screens to identify less evident nuisance compounds

Matic Proj et al.

DRUG DISCOVERY TODAY (2022)

添加到收藏夹

Article Chemistry, Medicinal

Solid-Phase Synthesis of Cereblon-Recruiting Selective Histone Deacetylase 6 Degraders (HDAC6 PROTACs) with Antileukemic Activity

Laura Sinatra et al.

Summary: In this study, we achieved the chemical knockdown of histone deacetylase 6 (HDAC6) using proteolysis targeting chimera (PROTAC) technology. Two series of cereblon-recruiting PROTACs were synthesized, allowing the rapid preparation of HDAC6 degrader mini libraries. Both PROTAC series demonstrated selective degradation of HDAC6 in leukemia cell lines.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

添加到收藏夹

Article Chemistry, Medicinal

Direct-to-Biology Accelerates PROTAC Synthesis and the Evaluation of Linker Effects on Permeability and Degradation

Charles E. Hendrick et al.

Summary: A platform using a D2B approach has been developed to accelerate optimization of PROTACs through studying the linker effects. By synthesizing and characterizing a large number of linker analogs, the platform provides valuable information on the structure-activity relationships for in-cell target engagement, degradation, permeability, and cell toxicity. The platform has the potential to expand training sets for more complex prediction models.

ACS MEDICINAL CHEMISTRY LETTERS (2022)

添加到收藏夹

Article Multidisciplinary Sciences

The E3 ligase adapter cereblon targets the C-terminal cyclic imide degron

Saki Ichikawa et al.

Summary: This study identifies C-terminal cyclic imides as physiological degrons for the ubiquitin E3 ligase substrate adapter cereblon (CRBN). The addition of these degrons induces CRBN-dependent ubiquitination and degradation of proteins. This discovery has significant implications for understanding the physiological and therapeutic engagement of CRBN.

NATURE (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Molecular glue CELMoD compounds are regulators of cereblon conformation

Edmond R. Watson et al.

Summary: This study reveals the structural importance and mechanism of action of Cereblon modulatory drugs through cryo-electron microscopy.

SCIENCE (2022)

添加到收藏夹

Article Cell Biology

Preclinical evaluation of proteolytic targeting of LCK as a therapeutic approach in T cell acute lymphoblastic leukemia

Jianzhong Hu et al.

Summary: T cell acute lymphoblastic leukemia (T-ALL) is an aggressive hematological malignancy. The LCK inhibitor dasatinib has shown efficacy against T-ALL, but its effect is temporary. Using the PROTAC approach, researchers developed a series of LCK degraders based on dasatinib, with lead compound SJ11646 exhibiting significant efficiency in cereblon-mediated LCK degradation. SJ11646 showed higher cytotoxicity and prolonged suppression of LCK signaling compared to dasatinib, both in vitro and in vivo. SJ11646 also showed binding affinity to several human kinases, making it a potential therapeutic agent for other cancers.

SCIENCE TRANSLATIONAL MEDICINE (2022)

添加到收藏夹

Article Chemistry, Medicinal

Fragment-Sized Thiazoles in Fragment-Based Drug Discovery Campaigns: Friend or Foe?

Matic Proj et al.

Summary: This study evaluates the usefulness of thiazoles and thiadiazoles in fragment screening campaigns and provides suggestions based on the profiling of a library of these compounds.

ACS MEDICINAL CHEMISTRY LETTERS (2022)

添加到收藏夹

Review Cell Biology

SALL4: An Intriguing Therapeutic Target in Cancer Treatment

Shiva Moein et al.

Summary: SALL4 is a critical factor for self-renewal ability and pluripotency of stem cells, and is tightly related to cancer occurrence and metastasis. It is an ideal target for cancer therapy due to its high expression in cancer cells and silence in adult tissues. However, targeting SALL4 faces various challenges.

CELLS (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Identification and structural basis of C-terminal cyclic imides as natural degrons for cereblon

Christopher Heim et al.

Summary: The study found that Cereblon (CRBN) can specifically recognize C-terminal aspartimide and aminoglutarimide residues, which are formed due to chain breaks in aging proteins and may mark potentially dysfunctional protein fragments.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2022)

添加到收藏夹

Article Chemistry, Multidisciplinary

Targeting the deubiquitinase USP7 for degradation with PROTACs

Arunima Murgai et al.

Summary: This study reports a novel approach to degrade USP7 using PROTACs based on a USP7 inhibitor scaffold. A highly selective USP7 degrader compound was discovered, which induced apoptosis in USP7-dependent cancer cells. This work unlocks a new drug target class for protein degradation.

CHEMICAL COMMUNICATIONS (2022)

添加到收藏夹

Review Chemistry, Multidisciplinary

PROTACs: past, present and future

Ke Li et al.

Summary: PROTACs are a type of molecules with novel event-driven mechanism, offering multiple advantages over traditional inhibitors, such as catalytic nature and targeted protein degradation, which may lead to improved therapeutic outcomes with reduced toxicity. However, further research and development efforts are needed to fully explore their potential.

CHEMICAL SOCIETY REVIEWS (2022)

添加到收藏夹

Review Chemistry, Multidisciplinary

E3 ligase ligand chemistries: from building blocks to protein degraders

Izidor Sosic et al.

Summary: Proteolysis-targeting chimeras (PROTACs) have shown great therapeutic potential and usefulness as molecular biology tools in recent years. These compounds induce targeted protein degradation by forming a ternary complex and leading to E3 ligase-mediated ubiquitination and proteasomal degradation. The field of PROTAC has grown substantially due to advancements in the discovery of non-peptidic E3 ligase ligands. Expanding the range of E3 ligands could contribute to broadening the scope of targeted protein degradation. This review focuses on the chemistry aspect of PROTAC design and serves as a blueprint for future research in this complex field.

CHEMICAL SOCIETY REVIEWS (2022)

添加到收藏夹

Article Chemistry, Multidisciplinary

Phenyl-Glutarimides: Alternative Cereblon Binders for the Design of PROTACs

Jaeki Min et al.

Summary: IMiDs and IMiD-based PROTACs rapidly hydrolyze in commonly utilized cell media, affecting their efficacy; Novel CRBN binders, phenyl glutarimide (PG) analogues, were designed with high affinity and improved stability; Discovery of PG PROTAC 4c as a potent degrader of BET proteins, supporting the utility of PG derivatives in CRBN-directed PROTACs design.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

On the correlation of cereblon binding, fluorination and antiangiogenic properties of immunomodulatory drugs

Christopher Heim et al.

Summary: CRBN is the substrate receptor of an E3 ubiquitin ligase complex and a target of thalidomide and its derivatives. The binding of IMiDs to CRBN alters the substrate specificity of the ligase, mediating effects exploited in cancer therapy. The involvement of other possible targets in the efficacy of IMiDs is not clear.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2021)

添加到收藏夹

Article Chemistry, Medicinal

Sweet and Blind Spots in E3 Ligase Ligand Space Revealed by a Thermophoresis-Based Assay

Samuel Maiwald et al.

Summary: Repurposing E3 ubiquitin ligases for targeted protein degradation via customized molecular glues or PROTACs is important, but limited by our incomplete understanding of E3 ligases and their ligand space. A quantitative assay based on the thermophoretic behavior of a custom reporter ligand offers a potential high-throughput screening method for discovering and characterizing E3 ligase ligands.

ACS MEDICINAL CHEMISTRY LETTERS (2021)

添加到收藏夹

Article Chemistry, Medicinal

Influence of Linker Attachment Points on the Stability and Neosubstrate Degradation of Cereblon Ligands

Alesa Bricelj et al.

Summary: The attachment points of CRBN ligands have a significant impact on their stability and degradation features, providing a blueprint for the development of future CRBN-based degraders with tailored properties.

ACS MEDICINAL CHEMISTRY LETTERS (2021)

添加到收藏夹

Article Chemistry, Medicinal

Identification of Potent, Selective, and Orally Bioavailable Small-Molecule GSPT1/2 Degraders from a Focused Library of Cereblon Modulators

Gisele Nishiguchi et al.

Summary: This study describes the design, synthesis, and screening of a large diverse library of thalidomide analogues against leukemia and medulloblastoma cell lines, leading to the discovery of potent GSPT1/2 degraders with selectivity over IMiD neosubstrates and high oral bioavailability in mice. Compound 6 (SJ6986) is proposed as a valuable tool for studying the role of GSPT1/2 and supports the utility of a diverse library of CRBN binders in targeting undruggable oncoproteins.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

添加到收藏夹

Review Chemistry, Multidisciplinary

E3 Ligase Ligands in Successful PROTACs: An Overview of Syntheses and Linker Attachment Points

Alesa Bricelj et al.

Summary: PROTACs, as a new and exciting class of therapeutic agents, consist of target binding units, linkers, and E3 ligase binding moieties, leading to ubiquitination and proteasomal degradation of target proteins through the chemically-induced formation of ternary complexes. This review provides in-depth analysis on the synthetic preparation of functionalized ligands for relevant E3 ligases, highlighting the importance of understanding preparative routes and chemistry of linker attachment for the assembly of final PROTACs.

FRONTIERS IN CHEMISTRY (2021)

添加到收藏夹

Article Chemistry, Multidisciplinary

Rapid synthesis of pomalidomide-conjugates for the development of protein degrader libraries

Duncan K. Brownsey et al.

Summary: This study presents a reliable and high-yielding strategy for preparing heterobifunctional pomalidomide-linkers, utilizing the trend of secondary amines providing higher yields than primary amines. Results show that this trend can be exploited to prepare high-yield pomalidomide homo-dimers and develop a new one-pot synthesis method for JQ1-pomalidomide conjugates.

CHEMICAL SCIENCE (2021)

添加到收藏夹

Article Reproductive Biology

Metabolism of JQ1, an inhibitor of bromodomain and extra terminal bromodomain proteins, in human and mouse liver microsomes

Feng Li et al.

BIOLOGY OF REPRODUCTION (2020)

添加到收藏夹

Article Chemistry, Multidisciplinary

Hydroxamic Acids Immobilized on Resins (HAIRs): Synthesis of Dual-Targeting HDAC Inhibitors and HDAC Degraders (PROTACs)

Laura Sinatra et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2020)

添加到收藏夹

Review Biochemistry & Molecular Biology

Targeted protein degradation: current and future challenges

Alexander Hanzl et al.

CURRENT OPINION IN CHEMICAL BIOLOGY (2020)

添加到收藏夹

Article Multidisciplinary Sciences

The CDK inhibitor CR8 acts as a molecular glue degrader that depletes cyclin K

Mikolaj Slabicki et al.

NATURE (2020)

添加到收藏夹

Article Chemistry, Medicinal

Understanding the Metabolism of Proteolysis Targeting Chimeras (PROTACs): The Next Step toward Pharmaceutical Applications

Laura Goracci et al.

JOURNAL OF MEDICINAL CHEMISTRY (2020)

添加到收藏夹

Article Chemistry, Multidisciplinary

Systematic exploration of different E3 ubiquitin ligases: an approach towards potent and selective CDK6 degraders

Christian Steinebach et al.

CHEMICAL SCIENCE (2020)

添加到收藏夹

Article Chemistry, Medicinal

De-Novo Design of Cereblon (CRBN) Effectors Guided by Natural Hydrolysis Products of Thalidomide Derivatives

Christopher Heim et al.

JOURNAL OF MEDICINAL CHEMISTRY (2019)

添加到收藏夹

Article Multidisciplinary Sciences

Small molecule degraders of the hepatitis C virus protease reduce susceptibility to resistance mutations

Melissanne de Wispelaere et al.

NATURE COMMUNICATIONS (2019)

添加到收藏夹

Article Oncology

Targeting bromodomain-containing protein 4 (BRD4) inhibits MYC expression in colorectal cancer cells

C. Otto et al.

NEOPLASIA (2019)

添加到收藏夹

Article Chemistry, Medicinal

A novel cereblon modulator for targeted protein degradation

Sung Ah Kim et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)

添加到收藏夹

Review Chemistry, Medicinal

Intramolecular hydrogen bonding: An opportunity for improved design in medicinal chemistry

Giulia Caron et al.

MEDICINAL RESEARCH REVIEWS (2019)

添加到收藏夹

Article Biochemistry & Molecular Biology

A MedChem toolbox for cereblon-directed PROTACs

Christian Steinebach et al.

MEDCHEMCOMM (2019)

添加到收藏夹

Article Chemistry, Multidisciplinary

PROTAC-mediated crosstalk between E3 ligases

Christian Steinebach et al.

CHEMICAL COMMUNICATIONS (2019)

添加到收藏夹

Article Biochemistry & Molecular Biology

Translation Termination Factor GSPT1 Is a Phenotypically Relevant Off-Target of Heterobifunctional Phthalimide Degraders

Mette Ishoey et al.

ACS CHEMICAL BIOLOGY (2018)

添加到收藏夹

Article Chemistry, Medicinal

Efficient Synthesis of Immunomodulatory Drug Analogues Enables Exploration of Structure-Degradation Relationships

George M. Burslem et al.

CHEMMEDCHEM (2018)

添加到收藏夹

Article Biochemistry & Molecular Biology

Plasticity in binding confers selectivity in ligand-induced protein degradation

Radoslaw P. Nowak et al.

NATURE CHEMICAL BIOLOGY (2018)

添加到收藏夹

Article Chemistry, Medicinal

Synthesis, Structural Characterization, and Antiangiogenic Activity of Polyfluorinated Benzamides

Christian Steinebach et al.

CHEMMEDCHEM (2018)

添加到收藏夹

Article Biochemistry & Molecular Biology

SALL4 mediates teratogenicity as a thalidomide-dependent cereblon substrate

Mary E. Matyskiela et al.

NATURE CHEMICAL BIOLOGY (2018)

添加到收藏夹

Article Biology

Thalidomide promotes degradation of SALL4, a transcription factor implicated in Duane Radial Ray syndrome

Katherine A. Donovan et al.

ELIFE (2018)

添加到收藏夹

Review Chemistry, Medicinal

Immobilized artificial membrane chromatography: from medicinal chemistry to environmental sciences

Fotios Tsopelas et al.

ADMET AND DMPK (2018)

添加到收藏夹

Article Chemistry, Multidisciplinary

Chemical Ligand Space of Cereblon

Iuliia Boichenko et al.

ACS OMEGA (2018)

添加到收藏夹

Article Hematology

The BET bromodomain inhibitor CPI203 improves lenalidomide and dexamethasone activity in in vitro and in vivo models of multiple myeloma by blockade of Ikaros and MYC signaling

Tania Diaz et al.

HAEMATOLOGICA (2017)

添加到收藏夹

Article Chemistry, Multidisciplinary

Searching for bioactive conformations of drug-like ligands with current force fields: how good are we?

Oya Gursoy et al.

JOURNAL OF CHEMINFORMATICS (2017)

添加到收藏夹

Article Hematology

The BET bromodomain inhibitor CPI203 improves lenalidomide and dexamethasone activity in in vitro and in vivo models of multiple myeloma by blockade of Ikaros and MYC signaling

Tania Diaz et al.

HAEMATOLOGICA (2017)

添加到收藏夹

Article Chemistry, Medicinal

Synthesis and Antiangiogenic Properties of Tetrafluorophthalimido and Tetrafluorobenzamido Barbituric Acids

Agnieszka Ambrozak et al.

CHEMMEDCHEM (2016)

添加到收藏夹

Article Chemistry, Medicinal

A FRET-Based Assay for the Identification and Characterization of Cereblon Ligands

Iuliia Boichenko et al.

JOURNAL OF MEDICINAL CHEMISTRY (2016)

添加到收藏夹

Article Multidisciplinary Sciences

A novel cereblon modulator recruits GSPT1 to the CRL4CRBN ubiquitin ligase

Mary E. Matyskiela et al.

NATURE (2016)

添加到收藏夹

Article Chemistry, Physical

Room-Temperature Practical Copper-Catalyzed Amination of Aryl Iodides

Christopher Deldaele et al.

CHEMCATCHEM (2016)

添加到收藏夹

Article Biochemistry & Molecular Biology

Selective Small Molecule Induced Degradation of the BET Bromodomain Protein BRD4

Michael Zengerle et al.

ACS CHEMICAL BIOLOGY (2015)

添加到收藏夹

Article Biochemistry & Molecular Biology

Anti-HIV diarylpyrimidine-quinolone hybrids and their mode of action

Tian-Qi Mao et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2015)

添加到收藏夹

Article Chemistry, Medicinal

Applications of Fluorine in Medicinal Chemistry

Eric P. Gillis et al.

JOURNAL OF MEDICINAL CHEMISTRY (2015)

添加到收藏夹

Article Multidisciplinary Sciences

Lenalidomide induces ubiquitination and degradation of CK1a in del(5q) MDS

Jan Kroenke et al.

NATURE (2015)

添加到收藏夹

Article Multidisciplinary Sciences

Structural Dynamics of the Cereblon Ligand Binding Domain

Marcus D. Hartmann et al.

PLOS ONE (2015)

添加到收藏夹

Article Multidisciplinary Sciences

Phthalimide conjugation as a strategy for in vivo target protein degradation

Georg E. Winter et al.

SCIENCE (2015)

添加到收藏夹

Article Multidisciplinary Sciences

Structure of the DDBI-CRBN E3 ubiquitin ligase in complex with thalidomide

Eric S. Fischer et al.

NATURE (2014)

添加到收藏夹

Article Biotechnology & Applied Microbiology

The role of ligand efficiency metrics in drug discovery

Andrew L. Hopkins et al.

NATURE REVIEWS DRUG DISCOVERY (2014)

添加到收藏夹

Article Multidisciplinary Sciences

Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells

Jan Kroenke et al.

SCIENCE (2014)

添加到收藏夹

Article Multidisciplinary Sciences

The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins

Gang Lu et al.

SCIENCE (2014)

添加到收藏夹

Article Chemistry, Medicinal

Intermolecular and Intramolecular Hydrogen Bonds Involving Fluorine Atoms: Implications for Recognition, Selectivity, and Chemical Properties

Claudio Dalvit et al.

CHEMMEDCHEM (2012)

添加到收藏夹

Article Biochemical Research Methods

XDS

Wolfgang Kabsch

ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2010)

添加到收藏夹

Article Biochemical Research Methods

Features and development of Coot

P. Emsley et al.

ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2010)

添加到收藏夹

Article Multidisciplinary Sciences

Identification of a Primary Target of Thalidomide Teratogenicity

Takumi Ito et al.

SCIENCE (2010)

添加到收藏夹

Review Chemistry, Multidisciplinary

Fluorine in medicinal chemistry

Sophie Purser et al.

CHEMICAL SOCIETY REVIEWS (2008)

添加到收藏夹

Review Pharmacology & Pharmacy

The role and significance of unconventional hydrogen bonds in small molecule recognition by biological receptors of pharmaceutical relevance

Gergely Toth et al.

CURRENT PHARMACEUTICAL DESIGN (2007)

添加到收藏夹

Article Biochemistry & Molecular Biology

The role of fluorine in medicinal chemistry

Poonam Shah et al.

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2007)

添加到收藏夹

Article Chemistry, Medicinal

Matched molecular pairs as a guide in the optimization of pharmaceutical properties; a study of aqueous solubility, plasma protein binding and oral exposure

Andrew G. Leach et al.

JOURNAL OF MEDICINAL CHEMISTRY (2006)

添加到收藏夹

Article Biochemical Research Methods

Development and optimization of a binding assay for the XIAP BIR3 domain using fluorescence polarization

Z Nikolovska-Coleska et al.

ANALYTICAL BIOCHEMISTRY (2004)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.